User menu

Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage.

Bibliographic reference Blot, L ; Marcelis, Annette ; Devogelaer, Jean-Pierre ; Manicourt, Daniel. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage.. In: British journal of pharmacology, Vol. 131, no. 7, p. 1413-21 (2000)
Permanent URL http://hdl.handle.net/2078.1/24094
  1. BARRACCHINI ANNALISA, FRANCESCHINI NICOLA, AMICOSANTE GIANFRANCO, ORATORE ARDUINO, MINISOLA GIOVANNI, PANTALEONI GIANCARLO, GIULIO ANTONIO, Biochemistry: Can Non-steroidal Anti-inflammatory Drugs Act as Metalloproteinase Modulators? An In-vitro Study of Inhibition of Collagenase Activity, 10.1111/j.2042-7158.1998.tb03369.x
  2. BITTER, Anal. Biochem., 4, 330 (1962)
  3. BORT, Drug Metab. Dispos., 24, 834 (1996)
  4. BRANDT, Am. J. Med., 83, 29 (1987)
  5. Brandt Kenneth D., Albrecht Marjorie, O'Bryan-Tear Gillies, Misoprostol Does Not Protect Articular Cartilage From Salicylate-Induced Suppression of Proteoglycan Synthesis, 10.1002/j.1552-4604.1991.tb03755.x
  6. DINCHUK, Nature, 378, 406 (1995)
  7. DINGLE, J.T. (1999). Non-steroidal anti-inflammatory drug administration in the treatment of osteoarthritis. In Osteoarthritis. Clinical and Experimental Aspects. ed. J-Y Reginster, J-P Pelletier, J. Martel-Pelletier & Y Henrotin. pp. 370-387. Berlin: Springer.
  8. Distel M., Mueller C., Bluhmki E., Fries J., Safety of Meloxicam: A Global Analysis of Clinical Trials, 10.1093/rheumatology/35.suppl_1.68
  9. GILROY, Nat. Med., 5, 698 (1999)
  10. GILROY, Eur. J. Pharmacol., 355, 211 (1998)
  11. GRETZER, Br. J. Pharmacol., 123, 927 (1998)
  12. HALLIWELL, B. (1995). Free radicals and rheumatoid disease. In Mechanisms and Models in Rheumatoid Arthritis. ed. Henderson, B., Edwards, J.C.W. & Pettipher, E.R. pp. 301-316. London: Academic Press.
  13. HARDINGHAM, T. (1999). Proteoglycans and glycosaminoglycans. In Dynamics of Bone and Cartilage Metabolism. ed. Seibel, M.J., Robins, S.P. & Bilezikian, J.P. pp. 71-81. San Diego: Academic Press.
  14. HARDINGHAM, J. Orthop. Res., 5, 36 (1987)
  15. HEINEGARD, J. Biol. Chem., 249, 4250 (1974)
  16. HISCOCK, Osteoarthritis Cartilage, 8, 120 (2000)
  17. Holmes M W A, Bayliss M T, Muir H, Hyaluronic acid in human articular cartilage. Age-related changes in content and size, 10.1042/bj2500435
  18. HOWELL, J. Rheumatol., 18, 138 (1991)
  19. HUGENBERG, J. Rheum., 20, 2128 (1993)
  20. HUNTER, Clin. Rheum., 15, 329 (1996)
  21. LI, Connect. Tissue Res., 19, 243 (1989)
  22. LIM, Cell, 91, 197 (1997)
  23. MANICOURT, Arthritis Rheum., 31, 538 (1988)
  24. Manicourt Daniel Henri, Egeren Anne Druetz-Van, Haazen Ludo, Deuxchaisnes Charles Nagant, Effects of tenoxicam and aspirin on the metabolism of proteoglycans and hyaluronan in normal and osteoarthritic human articular cartilage, 10.1111/j.1476-5381.1994.tb17111.x
  25. MANKIN, J. Bone Joint Surg., 53A, 523 (1971)
  26. MINTA, J. Rheumatol., 12, 751 (1985)
  27. MORHAM, Cell, 83, 473 (1995)
  28. MUIR, H. (1986). Current and future trends in articular cartilage research and osteoarthritis. In Articular Cartilage Biochemistry. ed. Kuettner, K., Schleyerbach, D.V.M. & Hascall, V.C. pp. 423-440. New York: Raven Press.
  29. NG, Arch. Biochem. Biophys., 316, 596 (1995)
  30. PITA, J.C. , MULLER, F.J. , MANICOURT, D.H. , BUCKWALTER, J.A. & RADCLIFFE, A. (1992). Early matrix changes in experimental osteoarthritis and joint disuse atrophy. In Articular Cartilage and Osteoarthritis. ed. Kuettner, K., Schleyerbach, D.V.M., Peyron, J.G. & Hascall, V.C. pp. 455-469. New York: Raven Press.
  31. POOLE, A.R. , ALINI, M. & HOLLANDER, A.P. (1995). Cellular biology of cartilage degradation. In Mechanisms and Models in Rheumatoid Arthritis. ed. Henderson, B., Edwards, J.C.W. & Pettipher, E.R. pp. 163-204. London: Academic Press.
  32. RAINSFORD K. D., YING C., SMITH F. C., Effects of Meloxicam, Compared with other NSAIDs, on Cartilage Proteoglycan Metabolism, Synovial Prostaglandin E2, and Production of Interleukins 1, 6 and 8, in Human and Porcine Explants in Organ Culture, 10.1111/j.2042-7158.1997.tb06030.x
  33. RIZKALLA, J. Clin. Invest., 90, 2268 (1992)
  34. SCHMASSMANN, Br. J. Pharmacol., 123, 795 (1998)
  35. SMITH, J. Biol. Chem., 271, 33157 (1996)
  36. TAKAHASHI, FEBS Lett., 460, 145 (1999)
  37. Turck D., Roth W., Busch U., A Review of the Clinical Pharmacokinetics of Meloxicam, 10.1093/rheumatology/35.suppl_1.13
  38. VANE J. R., Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, 10.1038/newbio231232a0
  39. VANE, Nature, 367, 215 (1994)
  40. VIGNON, Arthritis Rheum., 34, 1332 (1992)
  41. WALLACE, Gastroenterology, 115, 101 (1998)
  42. WARNER, Proc. Natl. Acad. Sci. U.S.A., 96, 7563 (1999)
  43. WOESSNER, Arch. Biochem. Biophys., 93, 440 (1961)